Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Apr 27, 2023; 15(4): 712-722
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.712
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.712
Table 3 Prevalence and severity of ost-endoscopic retrograde cholangiopancreatography pancreatitis in each group
| External use of mirabilite group (n = 9) | Blank group (n = 31) | P value | |
| Severity of PEP | 0.0231 | ||
| Mild | 9 (100.0%) | 16 (51.6%) | |
| Moderate | 0 (0.0%) | 13 (41.9%) | |
| Severe | 0 (0.0%) | 2 (6.5%) |
- Citation: Zeng JQ, Zhang TA, Yang KH, Wang WY, Zhang JY, Hu YB, Xiao J, Gu ZJ, Gong B, Deng ZH. External use of mirabilite to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in children: A multicenter randomized controlled trial. World J Gastrointest Surg 2023; 15(4): 712-722
- URL: https://www.wjgnet.com/1948-9366/full/v15/i4/712.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i4.712